Innate Pharma (IPHA) Sales of Property, Plant and Equipment (2019 - 2025)

Innate Pharma (IPHA) Sales of Property, Plant and Equipment (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Innate Pharma 163.06 Mn 163.06 Mn - 26,172.95

Historic Data

Download Data
DateValue
Dec 31, 2025 26,172.95
Dec 31, 2025 26,172.95
Dec 31, 2024 22,759.09
Dec 31, 2024 22,759.09
Dec 31, 2023 534,838.51
Dec 31, 2023 534,838.51
Dec 31, 2022 -1,137.95
Dec 31, 2022 -1,137.95
Dec 31, 2021 7,965.68
Dec 31, 2021 7,965.68
Dec 31, 2019 -11,379.54
Dec 31, 2019 -11,379.54